Showing results (161-170 of 289) with videos related to
Sort By:
Pageof 29
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1986
Synergistic antitumor effect of interferon and anti-idiotype monoclonal antibody in murine lymphomaT Y Basham, M S Kaminski, K Kitamura, et al.The Journal of Infectious Diseases|February 18, 1998
Lymph node human immunodeficiency virus RNA levels and resistance mutations in patients receiving high-dose saquinavirJ M Schapiro, M A Winters, M Vierra, et al.The Journal of Infectious Diseases|October 1, 1994
Failure of short-term CD4-PE40 infusions to reduce virus load in human immunodeficiency virus-infected personsR V Ramachandran, D A Katzenstein, R Wood, et al.The Journal of Infectious Diseases|March 1, 1993
Safety and efficacy of polyethylene glycol-modified interleukin-2 and zidovudine in human immunodeficiency virus type 1 infection: a phase I/II studyR Wood, J G Montoya, S K Kundu, et al.Antimicrobial Agents and Chemotherapy|December 1, 1979
Effects of interferon and adenine arabinoside treatment of hepatitis B virus infection on cellular immune responsesB Hafkin, R B Pollard, M L Tiku, et al.The American Review of Respiratory Disease|December 1, 1989
Frequency of Mycobacterium tuberculosis bacteremia in patients with tuberculosis in an area endemic for AIDSR W Shafer, R Goldberg, M Sierra, et al.Annals of Internal Medicine|January 1, 1982
UCLA conference. Interferon: immunobiology and clinical significanceE R Stiehm, L H Kronenberg, H M Rosenblatt, et al.Journal of Acquired Immune Deficiency Syndromes|January 1, 1992
Decrease in HIV provirus in peripheral blood mononuclear cells during zidovudine and human rIL-2 administrationA G Clark, M Holodniy, D H Schwartz, et al.The Journal of Infectious Diseases|April 1, 1993
Detection of human immunodeficiency virus type 1 in semen: effects of disease stage and nucleoside therapyK A Hamed, M A Winters, M Holodniy, et al.The Journal of Infectious Diseases|April 1, 1996
Polyethylene glycol-modified interleukin-2 and thymosin alpha 1 in human immunodeficiency virus type 1 infectionR Ramachandran, D A Katzenstein, M A Winters, et al.Pageof 29